结构:CCOC(=O)c1ccc(OCCOC)c(OCCOC)c1
HCID2808992

Ethyl 3,4-bis(2-methoxyethoxy)benzoate

C15H22O6298.33 g/molCAS 183322-16-9

IDENTITY

结构与身份

标准 SMILES
CCOC(=O)c1ccc(OCCOC)c(OCCOC)c1
InChIKey
VGFZRAVMWXHEJB-UHFFFAOYSA-N
分子式
C15H22O6
平均分子量
298.33 g/mol
单同位素质量
298.14163842

COMPUTED

结构计算性质

已同步
XLogP
2
极性表面积
63.2 Ų
氢键供体
0
氢键受体
6
可旋转键
11
重原子
21
形式电荷
0
复杂度
283

GHS

GHS 分类

来源:PubChem
GHS Classification

Not Classified;Reported as not meeting GHS hazard criteria by 1 of 1 companies. For more detailed information, please visit ECHA C&L website.

HAZARDS

危害信息

来源:PubChem
Regulatory Information

Status: Cease Manufacture Update: 06-11-2012 https://echa.europa.eu/registration-dossier/-/registered-dossier/6953

Hazard Classes and Categories

Not Classified

REGULATORY

法规信息

来源:PubChem
Regulatory Information

Status: Cease Manufacture Update: 06-11-2012 https://echa.europa.eu/registration-dossier/-/registered-dossier/6953

ALIASES

名称与别名

31
ethyl 3,4-bis(2-methoxyethoxy)benzoate183322-16-9Benzoic acid, 3,4-bis(2-methoxyethoxy)-, ethyl esterDTXSID40384593EC 605-991-9RefChem:138644DTXCID50335617605-991-93,4-Bis(2-methoxyethoxy)benzoic acid ethyl esterMFCD01935284C15H22O6Erlotinib Impurity 118PDJ499URB3SCHEMBL263238VGFZRAVMWXHEJB-UHFFFAOYSA-NCCG-41047AKOS000282910AC-8521FD16016IB31255

REACTIONS

参与反应

8
HRID124911

Training data from https://doi.org/10.1039/C8SC04228D (2/10)

作为反应物
HRID 124911 方程式

Training data from https://doi.org/10.1039/C8SC04228D (2/10) · 10.1039/C8SC04228D

查看条件与参与物
HRID201946

Training data from https://doi.org/10.1039/C8SC04228D (6/10)

作为反应物
HRID 201946 方程式

Training data from https://doi.org/10.1039/C8SC04228D (6/10) · 10.1039/C8SC04228D

查看条件与参与物
HRID670099

Training data from https://doi.org/10.1039/C8SC04228D (3/10)

作为反应物
HRID 670099 方程式

Training data from https://doi.org/10.1039/C8SC04228D (3/10) · 10.1039/C8SC04228D

查看条件与参与物